Barclays Raises Northrop Grumman (NOC) Price Target to $430

On October 22, 2026, Barclays maintained its Underweight rating on Northrop Grumman Corporation NOC, while adjusting its price target on the stock. The firm released its updated research note following recent market activity, setting a new target of $430.00 compared to its previous target of $419.00.

NOC Northrop Grumman Corporation

$552.65 ▼ -4.48% year to date

1M 3M YTD

Daily close · Oct 22, 2026

Barclays's Call on Northrop Grumman

In its research note on October 22, 2026, Barclays kept an Underweight rating on Northrop Grumman Corporation, lifting its price target from $419.00 to $430.00. The updated target sits below the broader market's expectations, contrasting with more bullish stances seen across other Wall Street firms.

Other Institutional Activity in Northrop Grumman

Capital International Investors cut its holdings by 1,244,057 shares, ending the period with 5,852,674 shares worth about $3,235,650,678. Franklin Resources, Inc. grew its holdings by 95,750 shares, ending with 3,374,876 shares worth about $1,865,800,114.

Northrop Grumman Corporation Stock Up 3.6%

Northrop Grumman Corporation recently traded around $553.25 as of October 22, 2026, compared to an event close of $552.85 on the same day. The shares sit below the 50-day moving average and below the 200-day moving average, while trading below the mean analyst price target.

Recent Earnings

Northrop Grumman Corporation reported trailing twelve month revenue of $42,892,001,280.00 with earnings of $31.68 per share. The company posted a net profit margin of 10.5% and a return on equity of 27.0%, alongside year-over-year revenue growth of 5.1%. Investors look ahead to the company's next earnings report, scheduled for January 26, 2027.

Dividend

Northrop Grumman Corporation pays an annual dividend rate of $9.88 per share, which translates to a dividend yield of 1.93%. The payout is supported by a dividend payout ratio of 29.9%.

Insider Buying and Selling at Northrop Grumman Corporation

Insider transactions included Roshan S. Roeder selling 1,754 shares on February 27, 2026, for $1,262,880.00 at an average price of $720.00. Kathryn G. Simpson sold 873 shares on March 2, 2026, for $650,385.00 at $745.00 per share. Director Mark A. Welsh III sold 95 shares on May 4, 2026, for $54,310.00, and another 95 shares on August 3, 2026, for $52,015.00.

Analysts Set New Price Targets

UBS maintained a Buy rating with a $698.00 price target on October 21, 2026, moving from a prior target of $694.00. BNP Paribas maintained an Outperform rating on October 21, 2026, raising its target from $540.00 to $600.00. Morgan Stanley kept an Overweight rating on October 21, 2026, lifting its target to $765.00 from $745.00. Guggenheim maintained a Buy rating on October 21, 2026, raising its target from $612.00 to $640.00. Across 24 analyst opinions, the stock carries a consensus buy recommendation and a mean price target of $630.00.

About Northrop Grumman

Northrop Grumman Corporation operates as an aerospace and defense technology company, supplying advanced systems and equipment to customers in the United States and internationally. The company organizes its operations across four primary divisions: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems, building aircraft, defense electronics, and space technology.

Bottom Line

Barclays remains cautious on Northrop Grumman Corporation with its Underweight stance, even as it bumps up its price target. Market participants will monitor upcoming earnings results on January 26, 2027, to gauge how defense spending and segment execution impact the company's financial results.